Duliege Anne-Marie
Insider CIK 1419579 · RIGL EVP & Chief Medical Officer · AFFY Chief Medical Officer · CCXI EVP, Chief of Strategic Dev.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2019-03-20 | 2019-03-22 | 75,000 | — | $0 | 75,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2019-01-23 | 2019-01-25 | 162,500 | — | $0 | 162,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise deriv | 2018-09-17 | 2018-09-19 | 115,500 | — | $0 | 268,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise deriv | 2018-09-17 | 2018-09-19 | 37,500 | — | $0 | 112,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2018-09-17 | 2018-09-19 | 115,500 | $3.50 | $404.3K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2018-09-17 | 2018-09-19 | 37,500 | $3.50 | $131.3K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise | 2018-09-17 | 2018-09-19 | 37,500 | $2.11 | $79.1K | 37,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise | 2018-09-17 | 2018-09-19 | 115,500 | $2.54 | $293.4K | 115,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise deriv | 2018-09-04 | 2018-09-06 | 16,500 | — | $0 | 383,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | M Exercise | 2018-09-04 | 2018-09-06 | 16,500 | $2.54 | $41.9K | 16,500 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2018-09-04 | 2018-09-06 | 16,500 | $3.51 | $57.9K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2018-07-02 | 2018-07-05 | 5,000 | $2.79 | $13.9K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2018-05-09 | 2018-05-11 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2018-04-20 | 2018-04-24 | 5,000 | $4.11 | $20.6K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2018-01-24 | 2018-01-26 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2017-07-05 | 2017-07-07 | 5,000 | $2.69 | $13.4K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2017-02-02 | 2017-02-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | S Sale | 2017-01-03 | 2017-01-13 | 5,000 | $2.41 | $12.1K | 0 | SEC↗ |
| RIGL RIGEL PHARMACEUTICALS INC | A Award deriv | 2016-05-05 | 2016-05-09 | 400,000 | — | $0 | 400,000 | SEC↗ |
| CCXI ChemoCentryx, Inc. | S Sale | 2014-11-18 | 2014-11-20 | 4,970 | $4.71 | $23.4K | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | A Award deriv | 2014-03-26 | 2014-03-28 | 335,000 | — | $0 | 335,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2013-01-30 | 2013-02-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2013-01-30 | 2013-02-01 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AFFY AFFYMAX INC | A Award | 2013-01-30 | 2013-02-01 | 5,000 | — | $0 | 28,125 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-11-01 | 2012-11-05 | 1,056 | $22.90 | $24.2K | 23,125 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-10-10 | 2012-10-12 | 9,704 | $24.00 | $232.9K | 23,125 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-09-13 | 2012-09-17 | 2,500 | — | $0 | 0 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-09-13 | 2012-09-17 | 16,666 | — | $0 | 23,334 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise deriv | 2012-09-13 | 2012-09-17 | 4,061 | — | $0 | 44,689 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-09-13 | 2012-09-17 | 4,061 | $7.99 | $32.4K | 56,056 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-09-13 | 2012-09-17 | 16,666 | $5.83 | $97.2K | 51,995 | SEC↗ |
| AFFY AFFYMAX INC | M Exercise | 2012-09-13 | 2012-09-17 | 2,500 | $4.36 | $10.9K | 35,329 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-09-13 | 2012-09-17 | 23,227 | $20.00 | $464.5K | 32,829 | SEC↗ |
| AFFY AFFYMAX INC | S Sale | 2012-05-25 | 2012-05-30 | 3,689 | $14.11 | $52.1K | 32,829 | SEC↗ |
| AFFY AFFYMAX INC | A Award deriv | 2012-01-31 | 2012-02-02 | 48,750 | — | $0 | 48,750 | SEC↗ |
| AFFY AFFYMAX INC | A Award | 2012-01-31 | 2012-02-02 | 8,125 | — | $0 | 32,829 | SEC↗ |